Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs.
Repository Usage Stats
Existing in vitro models of human skeletal muscle cannot recapitulate the organization and function of native muscle, limiting their use in physiological and pharmacological studies. Here, we demonstrate engineering of electrically and chemically responsive, contractile human muscle tissues ('myobundles') using primary myogenic cells. These biomimetic constructs exhibit aligned architecture, multinucleated and striated myofibers, and a Pax7(+) cell pool. They contract spontaneously and respond to electrical stimuli with twitch and tetanic contractions. Positive correlation between contractile force and GCaMP6-reported calcium responses enables non-invasive tracking of myobundle function and drug response. During culture, myobundles maintain functional acetylcholine receptors and structurally and functionally mature, evidenced by increased myofiber diameter and improved calcium handling and contractile strength. In response to diversely acting drugs, myobundles undergo dose-dependent hypertrophy or toxic myopathy similar to clinical outcomes. Human myobundles provide an enabling platform for predictive drug and toxicology screening and development of novel therapeutics for muscle-related disorders.
human skeletal muscle
Reproducibility of Results
Published Version (Please cite this version)10.7554/eLife.04885
More InfoShow full item record
Showing items related by title, author, creator, and subject.
Magnitude of spinal muscle damage is not statistically associated with exercise-induced low back pain intensity. Bishop, MD; Horn, ME; Lott, DJ; Arpan, I; George, SZ (Spine J, 2011-12)BACKGROUND CONTEXT: Findings on imaging of noncontractile anatomic abnormalities and the intensity of low back pain have weak associations because of false-positive rates among asymptomatic individuals. This association ...
Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Koeberl, DD; Austin, S; Case, LE; Smith, EC; Buckley, AF; Young, SP; Bali, D; Kishnani, PS (FASEB J, 2014-05)Effective dosages for enzyme replacement therapy (ERT) in Pompe disease are much higher than for other lysosomal storage disorders, which has been attributed to low cation-independent mannose-6-phosphate receptor (CI-MPR) ...
The incidence of unacceptable movement with motor evoked potentials during craniotomy for aneurysm clipping. Hemmer, LB; Zeeni, C; Bebawy, JF; Bendok, BR; Cotton, MA; Shah, NB; Gupta, DK; Koht, A (World Neurosurg, 2014-01)OBJECTIVE: To review the experience at a single institution with motor evoked potential (MEP) monitoring during intracranial aneurysm surgery to determine the incidence of unacceptable movement. METHODS: Neurophysiology ...